These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 110877)

  • 1. C3e: an acidic fragment of human C3 with leukocytosis-inducing activity.
    Ghebrehiwet B; Müller-Eberhard HJ
    J Immunol; 1979 Aug; 123(2):616-21. PubMed ID: 110877
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b.
    Meuth JL; Morgan EL; DiSipio RG; Hugli TE
    J Immunol; 1983 Jun; 130(6):2605-11. PubMed ID: 6602172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phagocytosis and intracellular killing of mucoid and nonmucoid variants of Pseudomonas aeruginosa by polymorphonuclear leukocytes: effect of specific immune sera.
    Gościniak G; Maresz-Babczyszyn J; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):467-79. PubMed ID: 6442852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A synthetic nonapeptide corresponding to the NH2-terminal sequence of C3d-K causes leukocytosis in rabbits.
    Hoeprich PD; Dahinden CA; Lachmann PJ; Davis AE; Hugli TE
    J Biol Chem; 1985 Mar; 260(5):2597-600. PubMed ID: 3871772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of low m.w., C3-bearing immunoglobulin in human serum.
    Jacobs RJ; Reichlin M
    J Immunol; 1983 Jun; 130(6):2775-81. PubMed ID: 6602181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of the third component of rat complement.
    Daha MR; Stuffers-Heiman M; Kijlstra A; van Es LA
    Immunology; 1979 Jan; 36(1):63-70. PubMed ID: 422228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunofixation of complement component C3 phenotypes in bloodstains after cellulose acetate electrophoresis.
    Morrison R; Noppinger K; Brown MG
    J Forensic Sci; 1985 Oct; 30(4):1221-5. PubMed ID: 4067545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aspects of quantification of components of human complement. I. Isolation of the C3 component of complement, preparation of a specific antiserum].
    Votruba T; Rákosník P; Vancurik J; Hrudková M
    Cesk Epidemiol Mikrobiol Imunol; 1983 Jul; 32(4):211-7. PubMed ID: 6225536
    [No Abstract]   [Full Text] [Related]  

  • 9. Purification and characterization of bovine complement component C3 and its cleavage products.
    Di Carlo AL; Paape MJ; Hellman J; Lilius EM
    Am J Vet Res; 1997 Jun; 58(6):585-9. PubMed ID: 9185962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
    Gerdes J; Klatt U; Stein H
    Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. II. Physico-chemical characterization of the activated complex.
    Miyama A; Kato T; Yokoo J; Kashiba S
    Biken J; 1975 Dec; 18(4):205-14. PubMed ID: 1218075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple method for preparation of C3c fragment from trypsinized serum-reacted zymosan.
    Chaplin H; Hoffmann NL; Monroe MC
    Transfusion; 1980; 20(3):341-7. PubMed ID: 7385330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitroblue-tetrazolium staining of human neutrophil granulocytes. Effects of stimulation with Pseudomonas antigens in the presence or absence of human Pseudomonas precipitins.
    Koch C; Hoiby N
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Dec; 81(6):787-94. PubMed ID: 4131384
    [No Abstract]   [Full Text] [Related]  

  • 14. The release of lysosomal enzymes from human polymorphonuclear leukocytes by human C3e.
    Ghebrehiwet B
    Clin Immunol Immunopathol; 1984 Feb; 30(2):321-9. PubMed ID: 6198120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and partial characterization of a C1q inhibitor from the membranes of human peripheral blood lymphocytes.
    Ghebrehiwet B; Hamburger M
    J Immunol; 1982 Jul; 129(1):157-62. PubMed ID: 6979565
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of an antiserum prepared against purified protease of pseudomonas aeruginosa (authors transl)].
    Sezen IY; Scharmann W; Blobel H
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):126-32. PubMed ID: 808047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation by Pseudomonas aeruginosa biofilms.
    Jensen ET; Kharazmi A; Garred P; Kronborg G; Fomsgaard A; Mollnes TE; Høiby N
    Microb Pathog; 1993 Nov; 15(5):377-88. PubMed ID: 8015418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of complement component C3 from Atlantic cod (Gadus morhua L.) and Atlantic halibut (Hippoglossus hippoglossus L.).
    Lange S; Dodds AW; Magnadóttir B
    Fish Shellfish Immunol; 2004 Feb; 16(2):227-39. PubMed ID: 15123326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of red blood cells strongly coated in vitro by C3 via the alternative pathway.
    Chaplin H; Freedman J; Massey A; Monroe MC
    Transfusion; 1980; 20(3):256-62. PubMed ID: 7385321
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors.
    Weis JJ; Law SK; Levine RP; Cleary PP
    J Immunol; 1985 Jan; 134(1):500-5. PubMed ID: 3880574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.